Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.71) by 25.35 percent. This is a 35.37 percent increase over losses of $(0.82) per share from the same period last year. The company reported quarterly sales of $46.488 million which missed the analyst consensus estimate of $48.920 million by 4.97 percent. This is a 162.94 percent increase over sales of $17.680 million the same period last year.